The recent interim Patents Court decision of Napp Pharmaceutical Holdings Limited v (1) Dr Reddy’s Laboratories (2) Sandoz Limited (and others) [2017] EWHC 1433 (Pat) provides guidance on how the court calculates damages associated with an interim injunction and...
There were two issues in this case regarding whether the application could be reinstated. Firstly, it had to be decided whether the deadline which was to be re-established could be the additional six-month period in which the renewal fee can still be paid with a...
The applications relate to compositions for dental impression materials. Claim 1 of the granted patent read as follows: “A dental impression material comprising a base paste and a catalyst paste, wherein the base paste comprises at least one polymerizable...
The overriding objective of the court system according to the civil procedure rules is that the court is able to deal with cases justly and at proportionate cost. It has long been a concern that justice might be denied to small entities pursuing patent claims because...
Facts and History On the face of it, the Eli Lilly v Actavis case seems straightforward. Eli Lilly is the proprietor of European patent No. 1313508 which claims:- “Use of pemetrexed disodium in the manufacture of a medicament for use in combination therapy for...
Background According to Article 3(a) of the SPC Regulation (European Parliament and Council Regulation 469/2009/EC of 6 May 2009 concerning the supplementary protection certificate for medicinal products) an SPC shall be granted for a medicinal product if the product...
Recent Comments